Skip to main content
Live · TradingView
Back to the NewsWire

Mindmedicinelaw

Published October 4, 2026 · Updated October 5, 2026

FDA Sets Approval Pathway for Psilocybin and LSD Therapies - The Psychedelic Journal

Read the full story at Mindmedicinelaw

The FDA has announced an official approval pathway for psilocybin, LSD, and other psychedelics , paving the way for prescribable use and reshaping.

Surfaced by 2 Google Alerts

  • Psychedelics
  • LSD